SNTI icon

Senti Biosciences
SNTI

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$9
329% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Jeffrey La Rosa
100% 1-yr SNTI win rate
21 Nov ‘25 14 days ago
HC Wainwright & Co
HC Wainwright & Co
Emily Bodnar
100% 1-yr SNTI win rate
14 Oct ‘25 1 month ago